血浆中性粒细胞明胶酶相关脂质运载蛋白水平与未来静脉血栓栓塞风险
该研究基于Tromsø队列的巢式病例对照研究,纳入416例VTE病例和848名年龄性别匹配对照,检测血浆NGAL水平。结果显示NGAL与整个随访期VTE风险无关,但随访限制为2年时最高vs最低四分位OR为3.87(95%CI 1.15-13.03),提示短暂风险增加。
要点
- 血浆NGAL整体与未来VTE风险无显著关联。
- 随访2年内高NGAL与VTE风险增加相关。
- 随访延长至5年该关联减弱。
核心结论
- 较高血浆NGAL水平与未来VTE风险短暂增加相关。
研究设计与样本
- 巢式病例对照研究,源自Tromsø研究队列(1994-2007),纳入416例VTE病例和848名年龄性别匹配对照。
主要发现
- 整个研究期间,NGAL最高vs最低四分位OR为1.02(95%CI 0.70-1.51)。
- 随访限制为2年时,NGAL最高vs最低四分位OR为3.87(95%CI 1.15-13.03)。
- 随访延长至5年时,OR为1.51(95%CI 0.82-2.80)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although neutrophils are suggested to play a role in the pathogenesis of venous thromboembolism (VTE), no study has investigated whether neutrophil gelatinase-associated lipocalin (NGAL), a marker of neutrophil activation, is associated with future VTE risk in the general population. AIM: To investigate the association between plasma NGAL levels and the risk of future VTE. METHODS: Plasma NGAL levels were measured in 416 VTE cases and 848 age- and sex-matched controls in a nested case-control study derived from the Tromsø study cohort (1994-2007). Logistic regression models were used to estimate odds ratios (ORs) with 95% confidence intervals (CIs) for VTE according to quartiles of plasma NGAL adjusted for age, sex, body mass index, arterial cardiovascular disease, cancer, and C-reactive protein. Separate analyses with follow-up restricted to the first 2- and 5 years after cohort inclusion were conducted to investigate potential short-term associations. RESULTS: We found no association between NGAL levels and risk of future VTE when analyzing the entire study period (OR for highest vs. lowest quartile of NGAL: 1.02, 95% CI: 0.70-1.51). However, when follow-up was restricted to 2 years, higher NGAL levels were associated with increased risk of future VTE (OR 3.87, 95% CI 1.15-13.03). The association was attenuated when follow-up was extended to 5 years (OR: 1.51, 95% CI: 0.82-2.80). CONCLUSION: Higher plasma NGAL levels were associated with a transiently increased risk of future VTE.
引用
- Eide NH, Morelli VM, Ueland T, et al. Plasma Neutrophil Gelatinase-Associated Lipocalin levels and risk of future incident venous thromboembolism. J Thromb Haemost. 2026. PMID: 42892331. doi:10.1016/j.jtha.2026.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。